Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers

27 Mar 2019

Abstract excerpt

High-grade serous ovarian carcinoma (HGSOC) is characterised by alterations in the p53 pathway. The expression levels of p53 isoforms have been shown to be associated with patient survival in several cancers. This study examined the predictive and prognostic effects of the expression levels of TP53 pre-mRNA splicing isoforms and TP53 mutations in tumour tissues in 40 chemotherapy responders and 29 non-responders...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ovarian cancer diagnosis and treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30918304
DOI: 10.1038/s41598-019-41706-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian CancersPMID 30918304Read ↗

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.Semantic proximity Read ↗

High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.Semantic proximity Read ↗

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers.Semantic proximity Read ↗

p53 Isoforms as Cancer Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma.Semantic proximity Read ↗

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)Semantic proximity Read ↗

TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analysesSemantic proximity Read ↗

Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized TherapeuticsSemantic proximity Read ↗

Poor survival with wild-type TP53 ovarian cancer?Semantic proximity Read ↗

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcomeSemantic proximity Read ↗

Optimized p53 immunohistochemistry is an accurate predictor of <i>TP53</i> mutation in ovarian carcinomaSemantic proximity Read ↗

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.